ARCHIVES

Hamburg Confirmed As FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Chronobiology Review Still Delayed

May 5, 1989

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978